328 related articles for article (PubMed ID: 34750486)
1. Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis.
MotieGhader H; Safavi E; Rezapour A; Amoodizaj FF; Iranifam RA
Sci Rep; 2021 Nov; 11(1):21872. PubMed ID: 34750486
[TBL] [Abstract][Full Text] [Related]
2. Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis.
Adhami M; Sadeghi B; Rezapour A; Haghdoost AA; MotieGhader H
BMC Biotechnol; 2021 Mar; 21(1):22. PubMed ID: 33711981
[TBL] [Abstract][Full Text] [Related]
3. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
[TBL] [Abstract][Full Text] [Related]
4. Discovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networks.
Xu J; Abdulsalam Khaleel R; Zaidan HK; Faisal Mutee A; Fahmi Fawy K; Gehlot A; Abbas AH; Arias Gonzáles JL; Amin AH; Ruiz-Balvin MC; Imannezhad S; Bahrami A; Akhavan-Sigari R
Cell Cycle; 2024 Feb; 23(4):405-434. PubMed ID: 38640424
[TBL] [Abstract][Full Text] [Related]
5. Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug-gene interaction networks analysis.
MotieGhader H; Tabrizi-Nezhadi P; Deldar Abad Paskeh M; Baradaran B; Mokhtarzadeh A; Hashemi M; Lanjanian H; Jazayeri SM; Maleki M; Khodadadi E; Nematzadeh S; Kiani F; Maghsoudloo M; Masoudi-Nejad A
Sci Rep; 2022 Jun; 12(1):9417. PubMed ID: 35676421
[TBL] [Abstract][Full Text] [Related]
6. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
Ting CT; Chen BS
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
[TBL] [Abstract][Full Text] [Related]
7. A new insight into sex-specific non-coding RNAs and networks in response to SARS-CoV-2.
Askari N; Hadizadeh M; Rashidifar M
Infect Genet Evol; 2022 Jan; 97():105195. PubMed ID: 34954105
[TBL] [Abstract][Full Text] [Related]
8. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
9. Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches.
Hoque MN; Sarkar MMH; Khan MA; Hossain MA; Hasan MI; Rahman MH; Habib MA; Akter S; Banu TA; Goswami B; Jahan I; Nafisa T; Molla MMA; Soliman ME; Araf Y; Khan MS; Zheng C; Islam T
Front Immunol; 2022; 13():918692. PubMed ID: 36059456
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the similarities and disparities of molecular mechanisms behind respiratory epithelium response to HCoV-229E and SARS-CoV-2 and drug repurposing, a systems biology approach.
Dehghan Z; Mirmotalebisohi SA; Mozafar M; Sameni M; Saberi F; Derakhshanfar A; Moaedi J; Zohrevand H; Zali H
Daru; 2024 Jun; 32(1):215-235. PubMed ID: 38652363
[TBL] [Abstract][Full Text] [Related]
11. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
Das AB
BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
[TBL] [Abstract][Full Text] [Related]
12. Cellular microRNAs target SARS-CoV-2 spike protein and restrict viral replication.
Vaddadi K; Gandikota C; Huang C; Liang Y; Liu L
Am J Physiol Cell Physiol; 2023 Aug; 325(2):C420-C428. PubMed ID: 37399496
[TBL] [Abstract][Full Text] [Related]
13. Construction of an autophagy interaction network based on competitive endogenous RNA reveals the key pathways and central genes of SARS-CoV-2 infection in vivo.
Chen Z; Wang X; Li L; Han M; Wang M; Li Z; Xie X; Du H; Xie Z; Zhang H
Microb Pathog; 2021 Sep; 158():105051. PubMed ID: 34153417
[TBL] [Abstract][Full Text] [Related]
14. Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection.
Banaganapalli B; Al-Rayes N; Awan ZA; Alsulaimany FA; Alamri AS; Elango R; Malik MZ; Shaik NA
Comput Biol Med; 2021 Aug; 135():104570. PubMed ID: 34157472
[TBL] [Abstract][Full Text] [Related]
15. Network-Based Data Analysis Reveals Ion Channel-Related Gene Features in COVID-19: A Bioinformatic Approach.
Zhang H; Feng T
Biochem Genet; 2023 Apr; 61(2):471-505. PubMed ID: 36104591
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders.
Nashiry MA; Sumi SS; Sharif Shohan MU; Alyami SA; Azad AKM; Moni MA
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33993223
[TBL] [Abstract][Full Text] [Related]
17. Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells.
Barbagallo D; Palermo CI; Barbagallo C; Battaglia R; Caponnetto A; Spina V; Ragusa M; Di Pietro C; Scalia G; Purrello M
Cell Mol Life Sci; 2022 Jan; 79(2):75. PubMed ID: 35039944
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory activation and immune cell infiltration are main biological characteristics of SARS-CoV-2 infected myocardium.
Zhang R; Chen X; Zuo W; Ji Z; Qu Y; Su Y; Yang M; Zuo P; Ma G; Li Y
Bioengineered; 2022 Feb; 13(2):2486-2497. PubMed ID: 35037831
[TBL] [Abstract][Full Text] [Related]
19. Potential core genes associated with COVID-19 identified via weighted gene co-expression network analysis.
Wu C; Wu Z; Chen Y; Huang X; Tian B
Swiss Med Wkly; 2022 Nov; 152():40033. PubMed ID: 36509426
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas.
Bhavya ; Pathak E; Mishra R
J Endocrinol Invest; 2022 Mar; 45(3):537-550. PubMed ID: 34669152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
